Pharma News – GPAT DISCUSSION CENTER

IRDAI allows Arogya Sanjeevani policy to be sold as group health insurance
- July 29, 2020
- Posted By : admin
- 0 Comment
The Insurance Regulatory and Development Authority of India (IRDAI) has now allowed general and standalone health insurers to offer the
Read More
AstraZeneca’s Farxiga Dazzles in Phase III Kidney Disease Trial
- July 29, 2020
- Posted By : admin
- 0 Comment
AstraZeneca reported successful results from its Phase III DAPA-CKD clinical trial of Farxiga (dapagliflozin) in end stage kidney disease (ESKD). The trial
Read More
Aarti Drugs revenue rises 34.34% yoy to Rs544.67cr in Q1
- July 29, 2020
- Posted By : admin
- 0 Comment
Aarti Drugs Limited on Monday announced the financial results of the quarter ended June 2020. The company recorded consolidated quarterly revenue
Read More
Immunic, Inc. Announces First Patients Enrolled in Investigator-Sponsored Phase 2 Clinical Trial
- July 29, 2020
- Posted By : admin
- 0 Comment
Immunic, Inc., a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases,
Read More
Unichem Laboratories gets USFDA nod for drug to treat irregular heartbeat
- July 23, 2020
- Posted By : admin
- 0 Comment
Drug firm Unichem Laboratories NSE 2.05 % on Wednesday said it has received approval from the US health regulator for
Read More